iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Mitral Valve Prolapse (MVP)

Mitral Valve Prolapse (MVP)

Overview and management.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Cardiology

Clinical Guidelines

NICE clinical guideline 64: Antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures
National
NICE guideline [NG208]: Heart valve disease presenting in adults
National
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Local
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Local
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex: risk stratification and management
Local
NICE clinical guideline 64: Prophylaxis against infective endocarditis in adults and children undergoing interventional procedures
Local

Recent iatroX Q&As

  • How should I manage a patient with mitral valve prolapse who presents with palpitations and anxiety?Updated: 8/22/2025
  • What are the indications for referring a patient with mitral valve prolapse to a cardiologist?Updated: 8/22/2025
  • How can I differentiate between mitral valve prolapse and other causes of similar symptoms in my patients?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play